Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Cochlear-optimized treatment planning in photon and proton radiosurgery for vestibular schwannoma patients.

23/11/2023
/ Publications

This study compared photon radiosurgery plans and IMPT plans to the clinically delivered photon treatment plans of 24 vestibular schwannoma patients to...

Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.

23/11/2023
/ Publications

This systematic review summarized results of the literature in the setting of patients treated with hypofractionated PT for benign lesions of the central...

New developments in PT: Motion Management, DynamicARC® and ConformalFLASH®

26/05/2021
/ Webinar
/
FLASH Therapy
ARC therapy
Motion Management

Watch our session from the virtual NAPT 2021 conference with Dr. Alonso Gutierrez and Swati Ghandi presenting topics related to ConformalFLASH®, DynamicARC® and...

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

23/11/2023
/ Publications

This study reported outcomes of 31 recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) patients treated with combined proton therapy and...

Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers.

23/11/2023
/ Publications

This study reviewed 483 patients with various types of head and neck cancer (HNC), and reported that the nasopharyngeal carcinoma (NPC) patients had a higher...

Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung Cancer.

23/11/2023
/ Publications

Published in the Red Journal, this is a brief report detailing a novel prospective feasibility and phase1/2 dose-scalation study of PBT as part of trimodality...

Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic review.

23/11/2023
/ Publications

To examine the superiority of PBT to photon-based RT in treating esophageal cancer patients, this systematic review included 23 original studies (1 randomized...

Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma.

23/11/2023
/ Publications

A review article by the group from National Cancer Center, Korea detailed the dosimetric and clinical benefits of PBT in the settings of early, intermediate and...

Clinical and Dosimetric Results of Proton or Photon Radiotherapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.

23/11/2023
/ Publications

Published in the Red Journal, this study from Taiwan retrospectively analyzed the outcomes of 159 patients with >5 cm non-metastatic HCC who underwent...

Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis.

23/11/2023
/ Publications

This study from Japan was set to compare the survival outcomes of PBT with those of radiofrequency ablation (RFA) in patients with treatment-naïve solitary HCC...